SCHEMBL7052367

SCHEMBL7052367

CCN(CC)CCOc1cccc(Nc2nccc(Cl)n2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGER Q15109 1/20 0.66
SRC P12931 4/20 0.55
FGFR1 P11362 3/20 0.55
FGFR2 P21802 2/20 0.55
FGFR4 P22455 2/20 0.55
FGFR3 P22607 2/20 0.55
YES1 P07947 1/20 0.53
EGFR P00533 3/20 0.50
AIMP2 Q13155 1/20 0.47
MAP3K5 Q99683 1/20 0.47
KDM4E B2RXH2 1/20 0.46
TSHR P16473 1/20 0.46
ABL1 P00519 2/20 0.45
PRKACA P17612 2/20 0.45
MET P08581 2/20 0.45
KDR P35968 2/20 0.45
WEE1 P30291 2/20 0.45
SYK P43405 2/20 0.45
CHEK1 O14757 1/20 0.45
RIPK2 O43353 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7052995 0.86 AGER (0.60) AGERSRCFGFR1FGFR2FGFR4
SCHEMBL4244136 0.83 EGFR (0.53) AGERSRCEGFRAIMP2MAP3K5
SCHEMBL7466120 0.83 AGER (0.67) AGERSRCFGFR1FGFR2FGFR4
SCHEMBL7464616 0.81 ABL1 (0.68) AGERSRCEGFRABL1PRKACA
SCHEMBL7464949 0.81 AGER (0.59) AGERSRCFGFR1FGFR2FGFR4
SCHEMBL13924608 0.80 SYK (0.66) AGERSRCFGFR1FGFR2FGFR4
SCHEMBL7057161 0.80 KDR (0.47) AGEREGFRABL1KDRIGF1R
SCHEMBL7660259 0.79 AGER (0.55) AGERSRCFGFR1FGFR2FGFR4
SCHEMBL18304247 0.79 AGER (1.00) AGERSRCFGFR1FGFR2FGFR4
SCHEMBL1736474 0.78 AGER (0.60) AGERSRCFGFR1FGFR2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003026666-A1 2-PHENYLAMINO-4- (5-PYRAZOLYLAMINO)-PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS, IN PARTICULAR, AS SRC KINASE INHIBITORS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed